Achieving a milestone: AMOR is now archived in Portico and indexed in CAS
Authors: Nadarajah R.N Sugitha 
Published: October 2016

<p>The journal of Advances in Modern Oncology Research (AMOR) is proud to announce its partnership with Portico, a leading digital preservation service provider, to ensure the long term accessibility of its published contents. In addition, it is now indexed by the gold standard of chemical information database Chemical Abstracts Services (CAS) after publishing only six bimonthly issues, dating back to October 2015. AMOR’s Editor-in-Chief Dr. Omar Abdel-Rahman proudly shares: “Our vision is to be far more than just a journal, we want to be a platform that publishes high quality cancer research contents from all over the world. I think we are progressing, at an acceptable pace, in that direction."</p><p> </p><p>The Portico archive is a “centralized repository of tens of thousands of e-journals, e-books, and other electronic content, replicated to ensure security,” according to the registry organization. “Content comes into the archive under formal preservation agreements with publishers. Content providers submit source files to Portico, and we repackage these source files into an archival format and provide long-term archival management and format migration as needed. Our approach is driven by our commitment to meeting clear preservation goals,” it states. </p><p> </p><p>AMOR’s Managing Editor Dr. TS Jong, when asked to comment about the impact of this development, adds: “AMOR is committed towards meeting the highest international publication standards and as such, has a clear archiving and indexing roadmap to sustain our growth. The journal acknowledges the importance of ensuring the continuous accessibility of our published articles in multiple repositories. Therefore, we are delighted with the recent partnership between AMOR and Portico, a well-known third-party repository service provider, to safeguard the long-term availability of our contents.”</p><p> </p><p>Archiving AMOR’s articles within Portico ensures that the materials published are always available for access. In addition, AMOR’s inclusion in Portico – one of the leading digital preservation services in the world – ensures that AMOR is a step-closer towards its goal of being indexed by PubMed or Medline eventually, as Portico is one of the certified repositories according to Medline’s requirement, Dr. Jong explains.</p><p> </p><p>Meanwhile, Chemical Abstracts Service is an internationally-renowned authority for chemical information that delivers the most complete, cross-linked, and effective digital information for scientific discoveries. CAS, a division of the American Chemical Society, is a source of chemical information and its databases are recognized as the ultimate ‘gold standard’ by the industry. Physically located in Columbus, Ohio, United States, CAS provides updated chemistry content which is maintained by hundreds of PhD scientists from all around the world. The content in CAS covers almost all information and accurate details acquired from thousands of journals, books, patent authorities, web sources, dissertations, conference proceedings, to name a few.</p><p> </p><p>According to Dr. Jong, AMOR is aware that being indexed in relevant databases would broaden its readership and consequently improve the journal’s standing among other oncology journals. “In this regard, we are excited about our inclusion in the CAS databases. This reflects the quality of our published contents and will certainly pave the way for subsequent recognitions by other academic databases,” he says. Dr. Abdel-Rahman goes on to explain, “Our vision for the development and progress of AMOR is to turn it into a benchmark of good quality cancer research and to disseminate this high-quality research to all those who are interested, without any barriers. That is why the indexing and archiving of AMOR into highly accessed biomedical indices is vital to achieve this goal.”</p><p> </p><p>AMOR’s future is bright and hopeful, the EIC says. “We promise our respectable readers and collaborators that AMOR will continue to develop itself and strive to include its contents in other highly accessed biomedical indices,” Dr. Abdel-Rahman concludes. ■</p>